Your browser doesn't support javascript.
loading
Sortilin-related receptor is a druggable therapeutic target in breast cancer.
Al-Akhrass, Hussein; Pietilä, Mika; Lilja, Johanna; Vesilahti, Ella-Maria; Anttila, Johanna M; Haikala, Heidi M; Munne, Pauliina M; Klefström, Juha; Peuhu, Emilia; Ivaska, Johanna.
Afiliação
  • Al-Akhrass H; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Pietilä M; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Lilja J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Vesilahti EM; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Anttila JM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Haikala HM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Munne PM; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Klefström J; Finnish Cancer Institute, FICAN South Helsinki University Hospital & Medical Faculty, University of Helsinki, Finland.
  • Peuhu E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Finland.
  • Ivaska J; Institute of Biomedicine, Cancer Research Laboratory FICAN West, University of Turku, Finland.
Mol Oncol ; 16(1): 116-129, 2022 01.
Article em En | MEDLINE | ID: mdl-34564954

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article